Management

Management

Barton P. Bandy
President and Chief Executive Officer

Mr. Bandy brings extensive leadership experience in health care, specifically in the bariatric and minimally invasive surgery segments. Most recently, Mr. Bandy was President and Chief Executive officer of BroadSpot Imaging Corporation, a privately held ophthalmic imaging company, and prior to that he was President of the Wellness Division at Alphaeon Corporation. He previously spent 10 years as the senior executive leading the Inamed and Allergan Health Divisions through the launch, growth and transition of LAP-BAND®. Mr. Bandy formerly held positions of increased responsibility in sales, marketing and professional education at Ethicon Endo-Surgery and Karl Storz Endoscopy, America.

    Tom Stankovich
    Chief Financial Officer

    Mr. Stankovich has over 25 years of executive leadership experience as the CFO for multiple public and private healthcare companies. Tom has spent the past nine years as the Global Senior Vice President and CFO of MP Biomedicals, a life sciences and molecular biology-diagnostics company. At MP Biomedicals he was responsible for financial planning and reporting, financial operations and strategy development along with the acquisition and integration of two international companies. Prior to MP Biomedicals, Tom served as CFO at Response Genetics where he successfully led the company through their initial public offering. Additionally, he served as CFO for Cobalis Corporation and for Ribapharm, where he also led the company through their initial public offering, which at the time became the second largest ever IPO in the biotechnology sector. Tom also held CFO positions at ICN International, which later changed names to Valeant Pharmaceuticals.

      Raj Nihalani, MD
      Chief Technology Officer & Business Development

      Dr. Nihalani has served as Chief Technology Officer & Business Development since May 2017, immediately following the Company’s acquisition of BarioSurg, Inc. From August 2008 to May 2017, Dr. Nihalani served as the Chief Executive Officer of BarioSurg, Inc., a privately held medical device company that developed a minimally invasive and reversible device to treat obesity and glycemic control. Dr. Nihalani has several US and international patents and has won awards for his inventions. He holds a medical degree from the University of Nagpur, India. Also, he held positions of increased responsibility at Endologix (ELGX), Medtronic (MDT), Acufocus, Inc, Rox Medical, & TrialMed Life Sciences.

        Kevin Condrin
        Senior Vice President, Market Development and Integration

        Mr. Condrin joined the Company as Senior Vice President, Commercial in May 2019. In 2021, Kevin moved to SVP Market Development and Integration to manage the company’s key strategic initiatives such as M&A discovery and integration, international business, and other key product and market development growth opportunities. Mr. Condrin has over 25 years of global experience in Sales Marketing, Business Development, Product Management, Procedure Development, and Training. Prior to joining ReShape Lifesciences, Kevin led the growth and development of numerous novel technologies and procedures primarily in the bariatric, endolumenal, laparoscopic, and advanced visualization spaces. In his many years as a medical device leader, he has held senior positions with increasing responsibilities while at USGI Medical, Medtronic, Covidien, Karl Storz, and Circon ACMI (now Olympus).

          Al Diaz
          Vice President, Operations and R&D

          Mr. Diaz joined the company as Vice President of Operations in August of 2021. Mr. Diaz possesses over thirty years of executive leadership experience in operations and engineering in implantable and non-implantable devices. Most recently, he served as Executive Vice President of Operations at ClearFlow, Inc. Mr. Diaz also held executive operational positions at the following companies: VasoNova, Inc. (Teleflex), Cardio Output Technologies, Inc., United States Manufacturing Company, Biolase Technology, Inc., Sorin Biomedica, Italy, Laerdal Medical, and Advanced Interventional Systems. Additionally, from 2003 until 2016, he was the Owner and President of Azmec, Inc., a manufacturer, and distributor of orthopedic soft goods.

            Dov Gal, DVM, MBA
            Vice President, Regulatory and Clinical Affairs and Compliance Officer

            Dr. Gal joined the Company as Vice President, Regulatory and Clinical Affairs in September 2019. With more than 30-year experience as a practicing veterinarian, academician at Tufts University School of Medicine and subsequently in the medtech industry. Prior to joining ReShape Lifesciences, Dr. Gal held R&D, clinical marketing and clinical affairs positions in private start-up, and medium to large public medical device companies. Specifically, Dr. Gal led the regulatory, clinical and quality departments at ClearFlow Inc., the clinical department of the Heart Valve Therapy business at Edwards Lifesciences, the clinical department at Broncus Technologies, and was the director of clinical research at Medtronic Vascular. Dr. Gal holds a BSc. degree in biology from Tel Aviv University, Tel Aviv Israel, Doctor of Veterinary Medicine degree from Pisa University, Pisa Italy, and an MBA degree from Boston University, Boston, Massachusetts.

              Brendan O’Connell
              Vice President, Finance and Corporate Controller

              Mr. Brendan O’Connell joined the Company in August 2019 as Vice President of Finance and Corporate Controller. Mr. O’Connell has over 20 years of accounting and finance experience, with over 12 years in the medical device space. Most recently, Mr. O’Connell served as Vice President of Finance and Corporate Controller for Biolase Incorporated. Mr. O’Connell holds a master’s degree from the University of California at Riverside.

                For investor inquiries, please contact:

                ReShape Lifesciences Investor Contact:
                Thomas Stankovich
                Chief Financial Officer
                949-276-6042
                ir@ReShapeLifesci.com

                Investor Contacts:
                Daniel Kontoh-Boateng
                Vice President
                The Ruth Group
                646-536-7028/7019
                dboateng@theruthgroup.com

                PRINT PAGE

                EMAIL PAGE